Contact

Rex Hospital Selects Merge Hemo to Optimize Workflow Efficiency merge, merge healthcare, rex hospital, merge hemo, merge cardio, merge cardiology, enterprise EHR Integrated solution delivers real-time documentation for the cardiac cath lab

Rex Hospital Selects Merge Hemo to Optimize Workflow Efficiency

Integrated solution delivers real-time documentation for the cardiac cath lab

Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, today announced that Rex Hospital, a member of UNC Health Care, has implemented Merge Hemo™ to automate their cath lab processes into their electronic patient record.

“Our cardiovascular volume has been growing by 20% annually for the past few years and we expect that growth to continue into the future,” explained Diana Massa, Director, Heart and  Vascular Services, Rex Hospital. “With plans for future expansion, we were looking for a best-of-breed solution that will help us standardize processes across seven heart, vascular and interventional radiology labs. With the help of the Merge Hemo system and consulting from Merge experts, we will significantly improve the workflow and efficiency throughout the department so we can deliver the best possible service to our patients.”

“As we evaluated the options, we selected Merge Hemo because of the workflow efficiencies it offered,” added Tom Hasley, Director of Clinical Systems for Heart and Vascular, Rex Hospital. “The ease of use, simplified touch-screen interface and ability to reduce manual entry of data will allow us to deliver the best possible care in the most efficient fashion. This will benefit our technologists, nurses, physicians, the department as a whole, and most importantly, our patients.”

Currently running in over 500 cardiac cath labs in some of the country’s largest health systems, Merge Hemo captures real-time data and documents procedural events to enable efficient workflow. "We are extremely proud that Merge Hemo has maintained its number one status as the category leader in cardiology hemodynamics with KLAS for two years running,” said Jeff Surges, CEO of Merge Healthcare. “We have worked diligently to ensure Merge Hemo provides seamless EHR integration, enhances workflow and reporting and provides quality patient care.”

The Merge Cardiology suite also includes Merge Cardio™, an enterprise-level image and information system that provides a single point of entry to the patient’s complete cardio record spanning  all cardiac modalities.

For more than 20 years, Merge Cardiology Solutions have been developed through a partnership with cardiologists and clinical staff, providing systems and tools with workflow and reporting that physicians are familiar with and comfortable using. This makes adoption of these systems successful so hospitals, labs and patients can benefit from the efficiencies and cost savings that come from best-of-breed information and imaging solutions.

About Merge
Merge is a leading provider of clinical systems and innovations that seek to transform healthcare.  Merge’s enterprise and cloud-based solutions for image intensive specialties provide access to any image, anywhere, any time. Merge also provides health stations, clinical trials software and other health data and analytics solutions that engage consumers in their personal health. With solutions that are used by providers and consumers and include more than 20 years of innovation, Merge is helping to reduce costs and improve the quality of healthcare worldwide. For more information, visit merge.com.

Cautionary Notice Regarding Forward-Looking Statements
The matters discussed in this news release may include forward-looking statements, which could involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.

Contact:
Lesley Weisenbacher
Vice President, Marketing
312-540-6623
lesley.weisenbacher@merge.com

 Download this press release >>

© 2017 IBM Watson Health. All Rights Reserved. Privacy | Terms | Email Signup | Sitemap